Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Gynecologic Cancer
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This research study is evaluating a new smartphone application named the "Helping Our Patients Excel (HOPE)" app with a Fitbit device. The SMART Study is a sub-study of the HOPE Trial. Both studies evaluate an almost identical intervention using a Fitbit device and smartphone app(s) with the goal of improving quality-of-life for women with gynecologic cancers.

Provided treatments

  • Device: Fitbit Zip
  • Other: HOPE App
  • Other: Standard of Care
  • Device: Fitbit Charge 2
  • Other: SMART Study Intervention
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03022032. The sponsor of the trial is Dana Farber Cancer Institute and it is looking for 140 volunteers for the current phase.
Official trial title:
The HOPE Trial: Helping Our Patients Excel, and The SMART Study: Symptom Management and Reporting